Dr. Mecker G Moller, MD, FACS 

Program Director Regional Therapies Program At University of Chicago Pritzker School of Medicine
University of Chicago
IL 60637 US
View Contact Information

Schedule a Conversation with a HIPEC Surgeon

The surgeon or staff member will make their best effort to call you at your requested time. If they become unavailable you will receive a text.

Fill out my online form.

Board Certified

Board certification by an ABMS Member Board is the premier, independently assessed credential attainable in medicine today.

Dr. Mecker G Moller, MD, FACS is affiliated with University of Chicago

Fellowship Experience

Surgical Oncologist

Additional Information

Mecker G. Möller, MD, FACS, is a Professor of Surgery at University of Chicago. She is a board-certified surgeon, who is a highly skilled and experienced surgical oncologist. Dr. Möller is an expert in both traditional and minimally invasive cancer therapies, including complex cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for locally advanced and metastatic cancers of the abdomen. Before moving to University of Chicago, Dr Moller spearhead and led the first HIPEC program in South Florida at the University of Miami.

In addition to her clinical practice, Dr. Möller is passionate about global surgery, surgical education research and using clinical and translational research to improve care for cancer patients. She is the Program Director of the Surgical Oncology Fellowship at University of Chicago. She has been inducted into the Academy of Master Surgeons Educators of the American College of Surgeons, one of the highest honors given to academic surgeons. Her work has published in multiple peer-reviewed articles in journals, including American Journal of Surgery, JAMA Surgery, Annals of Surgical Oncology, Journal of Surgical Education and Journal of Cancer. She has been a renowned speaker in multiple national and international conferences and part of the American Board Of Surgery EPA implementation group for Surgical Oncology.